Companies with a Health score of at least 4, ordered by Health score.
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs.
4basebio AG, an enabler of advances in medical science and patient care, focuses on manufacturing DNA products for therapeutic and other uses in Europe, the United States, and internationally.
PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products.
MorphoSys AG, together with its subsidiaries, develops and commercializes antibodies and peptides for therapeutic applications in the United States.
Formycon AG develops and markets biosimilar products.
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for out-patient and hospital-based sedation, anesthesia, and critical care services worldwide.
Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibodies, and specializes in antibody drug conjugates in Germany.
Elanix Biotechnologies AG, a tissue regeneration company, develops and commercializes products for acute wound care, dermatological, and gynecological applications, and provides cell technology services.
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids.
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel treatments for patients suffering from diseases that have unmet medical needs.
Medigene AG, a clinical stage immuno-oncology company, focuses on the development of T cell immunotherapies for the treatment of cancer.
CytoTools AG, a biotechnology company, develops a pipeline of disease modifying therapies.
Q2M Managementberatung AG provides provides management consultancy services.
Xlife Sciences AG focuses on the development of life sciences technologies.
Epigenomics AG, a cancer molecular diagnostics company, develops and commercializes blood-based diagnostic tests across multiple cancer indications with high medical needs in Europe, North America, Asia, and internationally.
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide.